Search Results for “diagnostic” – Page 52 – media

Identifying ‘hallmark’ Parkinson’s disease protein buildup could aid early detection, improved diagnosis and treatment

A technique that identifies the build-up of abnormal protein deposits linked to Parkinson’s disease could aid in early detection and play a key role in the disease’s clinical diagnosis and characterization, according to research published in The Lancet Neurology journal. Findings from the study confirm that the technique—known as α-synuclein seed amplification assay (αSyn-SAA)—can accurately detect people with the neurodegenerative disease and suggest it can identify at-risk individuals and those with early, non-motor symptoms prior to diagnosis. The presence of misfolded α-synuclein protein aggregates in the brain is the pathological hallmark of Parkinson’s disease. Co-lead author Professor Andrew Siderowf, of the University of Pennsylvania Perelman School of Medicine (U.S.) and Parkinson Progression Marker Initiative (PPMI) investigator, says, “Recognizing heterogeneity in underlying pathology among patients with Parkinson’s disease has been a major challenge. Identifying an effective biomarker for Parkinson’s disease pathology could have profound implications for the way we treat the condition, potentially ...
- Source: drugdu
- 123
- April 13, 2023
A Future Without Screening Colonoscopies?

Kerry Dooley Young April 05, 2023 US regulators may soon clear blood-based biomarker tests for colorectal cancer (CRC), expanding potential options for patients seeking more convenient forms of screening. Most recently, Guardant Health, Inc, announced the completion of its US premarket approval application for its Shield blood test to screen for CRC. Approval by the US Food and Drug Administration (FDA) would position Guardant to later secure Medicare coverage for its test. Rival companies, including CellMax Life, Freenome, and Exact Sciences, which already offers the stool-based Cologuard product, are pursuing similar paths in their development of blood tests for CRC. If these companies succeed, clinicians and patients could have a choice of several FDA-approved tests in a few years. “They’re coming, and they will be increasingly widely used,” said David A. Johnson, MD, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, ...
- Source: drugdu
- 121
- April 12, 2023
Roche teams up with Lilly to validate Alzheimer’s blood test

March 22 (Reuters) – Roche (ROG.S) and Eli Lilly and Co (LLY.N) are joining forces to develop a blood test for Alzheimer’s disease, and plan to kick off a two-year clinical trial involving hundreds of volunteers with the aim of winning U.S. regulatory approval. The effort, unveiled in a statement on Wednesday, comes as Lilly as well as Eisai (4523.T) and Biogen (BIIB.O) are gearing up to sell drugs aimed at slowing the advance of the mind-robbing illness, but their use will require a diagnosis at earlier disease stages than is the norm today. Roche Holding AG would recruit several hundred volunteers with early signs of dementia over the next 18 to 24 months with trial data potentially ready for a U.S. regulatory filing in 2025, Bruce Jordan, leader of Personalized Healthcare Solutions at Roche Diagnostics, told Reuters. The U.S. Food and Drug Administration has asked Roche to recruit a significant number of patients at primary care facilities ...
- Source: drugdu
- 144
- March 22, 2023
Scientists Develop New Blood Test for Detecting Alzheimer’s Disease

Researchers at Washington University School of Medicine in St. Louis have developed a new blood test that can detect Alzheimer’s disease in its early stages. The test looks for a specific protein called tau, which is known to be a key biomarker of Alzheimer’s. Currently, the most common way to diagnose Alzheimer’s disease is through cognitive testing and brain imaging scans. However, these methods can be costly and invasive. Additionally, by the time symptoms appear, the disease has already caused significant damage to the brain. The new blood test offers a non-invasive and potentially more accessible way to diagnose Alzheimer’s disease early on, when treatments may be more effective. The study, published in the journal Nature Medicine, involved analyzing blood samples from 158 individuals, including healthy adults, individuals with mild cognitive impairment, and individuals with Alzheimer’s disease. The researchers used a technique called mass spectrometry to measure levels ...
- Source: drugdu
- 138
- March 21, 2023
Organoid Intelligence

Researchers just announced a plan to eventually create “organoid intelligence,” or OI. They plan to grow clumps of brain cells called organoids and create technology that would allow us to turn those clumps of cells into powerful and efficient computers. The technology is only in its infancy, but it has implications for everything from computer memory to neurological diagnostics. The human brain is a wonderful and complicated organ. Despite decades of study and scientific progress, there’s still a lot we don’t know about how it works and why it behaves the way it does. But we know it’s powerful. It might not be as quick to solve complex equations as a computer, but it’s wildly more energy-efficient and significantly better at both learning and memory. And recently, researchers have been looking into how combine a brain and a computer, giving us the power of a human mind at our fingertips. ...
- Source: drugdu
- 127
- March 20, 2023
Siemens and Sysmex Sign Global Hemostasis Supply Agreement

Image: Sysmex and Siemens have established global agreement to supply hemostasis instruments and reagents as OEMs (Photo courtesy of Sysmex) Sysmex Corporation (Kobe, Japan) and Siemens Healthcare Diagnostics Inc. (Siemens Healthineers, Erlangen, Germany) have signed a global OEM agreement on hemostasis products under which each company will supply the other with their products in the diagnostic field of hemostasis on an OEM basis. Both Siemens and Sysmex provide hemostasis products used in testing for blood clotting disorders, preoperative bleeding risk management, and the monitoring of patients receiving anticoagulant therapy medications. Following their global agreement on distribution, sales, and services for hemostasis products signed in 1995, the two companies have since then developed a strong partnership and gone on to become one of the leading solution providers in the global hemostasis space. Over this period, the companies have further expanded their capabilities and gained strength by introducing new innovations in ...
- Source: drugdu
- 232
- March 15, 2023
KIHE – Kazakhstan International Healthcare Exhibition

For over 25 years the Kazakhstan International Healthcare Exhibition - KIHE - is the largest demonstration platform of achievements in the field of scientific and practical medicine and pharmaceuticals in Central Asia. KIHE annually brings together doctors of various specialties, pharmacists, government officials and businesspersons from different countries.
- Source: drugdu
- 1,653
- March 31, 2022
Healthcare Exhibition KIHE
FIME 2022

FIME 2022 Miami Medical Supplies and Equipment Exhibition is organized by Infurman Group and its cycle is as follows: The annual Exhibition will be held on July 27, 2022, located at 1901 Convention Center Drive Miami Beach, USA. FIME is the largest medical professional fair in the Southeastern United States. Exhibition is characterized by regional and international have both, in addition to the main exhibitors and professional buyers from the United States of Florida, show using city adjacent to the Caribbean advantage geographical location, attracted a large number of exhibitors and professional buyers from Latin American countries, a large number of products and equipment through transit to Florida Caribbean countries and markets.
- Source: drugdu
- 1,882
- March 31, 2022
FIME medical equipment
Zdravookhraneniye 2021 Moscow Russia

The Russian Ministry of Health Care included the Russian Health Care Week 2021 in their schedule of research and practice events for this year. The Week is Russia's largest health care project. It brings together a series of international trade shows and major congresses such as the Zdravookhraneniye 2020 international exhibition for medical engineering, products and consumables, the Healthy Lifestyle 2021 international exhibition for rehabilitation and preventive treatment facilities, medical aesthetics, pharmaceuticals and products for healthy lifestyle, the MedTravelExpo 2021. Medical Clinics. Health and Spa Resorts international exhibition for medical and wellness services, health improvement and medical treatment, the For Healthy Life 2020 international forum on non-communicable disease prevention and promotion of healthy lifestyle, and other major events.
- Source: drugdu
- 1,004
- August 26, 2021
Zdravookhraneniye
FIME – 2021

For 30 years, FIME has brought together manufacturers spearheading innovation in medical devices and equipment and the distributors and buyers looking to help expand into new verticals and markets. FIME is the annual must-attend event for everyone in the healthcare industry in the Americas.
- Source: drugdu
- 1,175
- August 26, 2021

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.